INVESTIGATION ALERT The Schall Law Firm Announces it is Investigating Claims Against AirSculpt Technologies, Inc. and Encourages Investors with Losses to Contact the Firm
AIRS Stock | USD 5.98 0.05 0.83% |
Slightly above 62% of Airsculpt Technologies' investor base is looking to short. The analysis of overall sentiment of trading Airsculpt Technologies stock suggests that many investors are alarmed at this time. Airsculpt Technologies' investing sentiment can be driven by a variety of factors including economic data, Airsculpt Technologies' earnings reports, geopolitical events, and overall market trends.
Airsculpt |
LOS ANGELES, CA ACCESSWIRE April 8, 2024 The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of AirSculpt Technol
Read at accesswire.com
Airsculpt Technologies Fundamental Analysis
We analyze Airsculpt Technologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Airsculpt Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Airsculpt Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Airsculpt Technologies is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Airsculpt Technologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Airsculpt Technologies stock to make a market-neutral strategy. Peer analysis of Airsculpt Technologies could also be used in its relative valuation, which is a method of valuing Airsculpt Technologies by comparing valuation metrics with similar companies.
Peers
Airsculpt Technologies Related Equities
AMED | Amedisys | 0.28 |
| ||
ACHC | Acadia Healthcare | 0.44 |
| ||
ADUS | Addus HomeCare | 0.85 |
| ||
ENSG | Ensign | 1.67 |
| ||
EHC | Encompass Health | 1.93 |
| ||
SEM | Select Medical | 2.46 |
| ||
EHAB | Enhabit | 2.56 |
| ||
SGRY | Surgery Partners | 2.73 |
| ||
PNTG | Pennant | 2.82 |
| ||
AVAH | Aveanna Healthcare | 3.43 |
| ||
UHS | Universal Health | 3.89 |
| ||
CCEL | CryoCell International | 4.05 |
| ||
INNV | InnovAge Holding | 4.23 |
| ||
TOI | Oncology Institute | 6.25 |
|
Additional Tools for Airsculpt Stock Analysis
When running Airsculpt Technologies' price analysis, check to measure Airsculpt Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Airsculpt Technologies is operating at the current time. Most of Airsculpt Technologies' value examination focuses on studying past and present price action to predict the probability of Airsculpt Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Airsculpt Technologies' price. Additionally, you may evaluate how the addition of Airsculpt Technologies to your portfolios can decrease your overall portfolio volatility.